Ledger.Open graph →
SEC Form D · filed January 23, 2023

Morphoceuticals, Inc

Offering
$9.8M
Sold
$9.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MARBLEHEAD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Alexander R. Pickett · Marblehead, MADirectorMichael R. Hufford · Pittsburgh, PAExec · DirectorRosemarie R. Hunziker · Falls Church, VADirectorMichael R. Levin · Marblehead, MAPromoterDavid R. Gill · Indianapolis, INExecDavid R. Kaplan · Marblehead, MAPromoterAmy R. Kruse · Annapolis, MDDirectorAlexander R. Pickett · Marblehead, MADirectorMichael R. Levin · Marblehead, MAPromoterDavid R. Gill · Indianapolis, INExecDavid R. Kaplan · Marblehead, MAPromoterAmy R. Kruse · Annapolis, MDDirectorMichael R. Hufford · Pittsburgh, PAExec · DirectorRosemarie R. Hunziker · Falls Church, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗